Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05464992

Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
800 (estimated)
Sponsor
Centre Paul Strauss · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Standard Magnetic Resonance Imaging (MRI) is based on the excitation of hydrogen nuclei that are presents in water molecules, which abundance in human body allows for obtention of superior contrast. However, assessing the presence of other molecules than water in tissues is also of great clinical interest to probe metabolites related to physiological body function and pathological conditions. Chemical exchange saturation transfer (CEST) allow to overcome some limitations of proton magnetic resonance spectroscopy (1H-MRS) by exploiting chemical properties of the targeted molecule through a continuous process of re-saturation and exchange, and thus detecting it with increased sensitivity, from two orders of magnitude. Moreover, CEST technique is based on imaging sequences and can therefore benefit from well-known fast acquisition strategies, as well as improved spatial resolution.

Detailed description

For this study the investigators propose to include an additional CEST sequence in standard PET/MRI exam in order to obtain a cartography with biochemical informations from tissues in patients with glioma or brain metastases.

Conditions

Interventions

TypeNameDescription
OTHERAdditional CEST sequences during PET/MRI examCE-Marked Advanced Technology Software Modules (ATSM) for Magnetic Resonance Imaging from General Electric Healthcare

Timeline

Start date
2022-12-28
Primary completion
2036-12-28
Completion
2036-12-28
First posted
2022-07-19
Last updated
2026-02-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05464992. Inclusion in this directory is not an endorsement.